KOSPI Jumps Above 2150... KOSDAQ Also Rises Over 1% Intraday

[Asia Economy Reporter Oh Ju-yeon] Following the rise in the US stock market centered on large tech stocks based on earnings results the previous day, the domestic stock market also started higher on the 24th. Both the KOSPI and KOSDAQ indices showed strength, rising by more than 1% during the session.

As of 9:10 a.m. that day, the KOSPI recorded 2150.87, up 0.92% from the previous trading day. The KOSPI opened at 2145.93 and showed a rise of over 1%, reaching as high as 2153.89, fluctuating around the 2150 level.

Among the top market capitalization stocks, Samsung Electronics (1.56%), SK Hynix (0.59%), Samsung Biologics (3.37%), Celltrion (3.30%), LG Chem (1.79%), and Samsung SDI (0.26%) rose. On the other hand, NAVER (-1.09%), Kakao (-1.24%), and SK (-2.58%) declined.

By investor type, individuals net bought stocks worth 121.1 billion KRW in the KOSPI market, while foreigners and institutions net sold stocks worth 56.3 billion KRW and 67.4 billion KRW, respectively.

The KOSDAQ index recorded 759.88, up 0.88% from the previous trading day. After opening at 758.15, the KOSDAQ index rose to 761.70 during the session, marking a 1.12% increase.

Among the top market capitalization stocks, Celltrion Healthcare (1.75%) and Celltrion Pharm (0.64%) rose, while Seegene (0.36%) and Pearl Abyss (0.96%) also saw slight gains. HL Biopharma (-1.46%) and Alteogen (-1.39%) declined.

Meanwhile, Hugel surged 27.08% during the session on news of a 2-for-1 stock dividend. At this time, Hugel was trading at 603,300 KRW, up 19.42% from the previous day, setting a new 52-week high.

Seo Sang-young, a researcher at Kiwoom Securities, said, "One characteristic of the US stock market is that stocks that have risen are those with increased expectations for earnings improvement," adding, "While the global stock market has been strong due to liquidity, fundamentals (corporate earnings) will now be a key variable."

He added, "The domestic stock market is expected to go through a process of digesting selling pressure except for stocks with high expectations for earnings improvement."

This content was produced with the assistance of AI translation services.